Jafron Biomedical Co.,Ltd.

SZSE:300529.SZ

20.36 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q1
Operating Activities:
Net Income 267.74284.76612.837146.14780.979196.5311.815125.294412.949335.207333.728242.945336.835283.306247.83186.781256.204184.425152.91112.151176.177129.58496.0895.947119.97689.97780.95854.44489.3859.63162.88338.72753.61446.89565.09443.62242.29737.826
Depreciation & Amortization 33.54333.54331.041-44.82125.4525.4521.33221.33219.9819.9816.55316.55312.81612.81636.727-17.54317.543029.789-13.76213.762021.793-9.8119.811016.198-7.8057.805014.618-7.1047.1043.6659.26501.5591.523
Deferred Income Tax 000135.44-141.5190159.863-235.412386.2300000000000000000000000000000
Stock Based Compensation 18.303019.097-8.3578.3570-8.735-1.3561.35607.5181.222-1.222022.351-8.8398.839017.12707.792011.31205.40205.01901.896000000000
Change In Working Capital 58.3920259.022-79.36979.3690-160.645340.73-340.730-178.077144.821-144.8210-89.343159.164-159.1640-48.30370.366-70.3660-44.07727.108-27.1080-22.341-7.2837.2830-36.94241.952-41.952-27.502-29.3330-8.699-5.33
Accounts Receivables -25.770277.225-92.89192.8910-7.902313.314-313.3140-110.412116.503-116.5030-83.405161.566-161.5660-34.22678.436-78.4360-39.51929.582-29.5820-31.7431.091-1.0910-26.02129.386-29.3860-24.604012.122-12.122
Change In Inventory 64.9130-37.29913.522-13.5220-152.74327.416-27.4160-75.93127.444-27.4440-28.2886.437-6.4370-31.204-0.2780.2780-15.872.928-2.92804.383-6.4776.4770-10.92112.567-12.567-3.286-4.7290-1.097-1.156
Change In Accounts Payables 0008.357-8.35708.586-1.761.7600000000000000000000000000000
Other Working Capital 19.249019.097-8.3578.3570-8.5861.76-1.7608.2660.874-0.874022.351-8.8398.839017.127-7.7927.792011.312-5.4025.40205.019-1.8961.8960000-24.21600-7.602-4.173
Other Non Cash Items 13.627224.857351.3944.305144.798-25.45-11.815-125.294-66.836-207.141285.844-242.945-336.835-283.306-247.83-186.781-256.204-184.425-152.91-112.151-176.177-129.584-96.08-95.947-119.976-89.977-80.958-54.444-89.38-59.631-62.883-38.727-53.6141.08-65.094-43.6220.5470.65
Operating Cash Flow 247.824509.624333.19153.344197.434196.5311.815125.294412.949128.067583.275173.824262.214242.532462.919154.753190.257149.559196.868131.878157.08692.662159.77150.829119.60953.86797.07546.171110.43850.41285.70136.11332.68524.13788.84245.96135.70434.67
Investing Activities:
Investments In Property Plant And Equipment -32.238-95.865-146.291-28.42-37.122-35.42-57.996-132.02-139.688-146.183-101.751-148.106-113.052-174.502-143.321-103.974-67.06-42.759-41.589-86.414-49.045-43.623-43.487-93.639-27.078-9.322-64.164-55.363-53.883-4.319-5.619-4.018-10.113-8.904-14.251-13.651-20.082-13.418
Acquisitions Net 0.0010.0690.5832.7441.2548.0236.72100.0060-0.151148.394113.903174.5020067.0642.759-3.30386.41446.07643.62314.58693.66127.0789.322-7.22450.48853.8834.3190000000-0.5
Purchases Of Investments -857.5-1,168-15000-100-300-0.006-1,650-1,330-1,611-711.5-9010-420-199.5-690.5-122.793-1,308-609.026-802.974-1,028-612-1,170.178-806.022-100-1,283.16-506.837-400.003-1000000000
Sales Maturities Of Investments 6084220000100.048300.821-1.0311,813.4262,090.8716.475704.618907.812427.0160505.336392.8421,104.657367.205591.819808.9161,035.52622.2341,090.188815.735907.786502.595909.297100.74800000000
Other Investing Activites -243.848-743.403-14.417000-0.184-00.0060.179-0.151-148.106-113.052-174.5021.314-420-67.56-42.7590.013-86.414-49.045-43.623-43.504-93.623-27.078-9.3220.068-55.363-53.883-4.319202.094-199.9980.1180.0010-000.001
Investing Cash Flow -281.738-841.796-160.708-25.676-35.869-27.396-51.411-131.199-140.71317.422658.898-1,042.344-119.084-167.691285.009-523.974238.276-340.417936.985-1,027.208-69.219-37.682-64.884-83.367-107.0680.391736.467-840.804348.576-303.57496.475-204.016-9.996-8.903-14.251-13.651-20.082-13.917
Financing Activities:
Debt Repayment -117.923-125.323-56.771-259.589-9.67-328.634-126.126000-998.302000000000000000000000000000
Common Stock Issued 000-5.73315.4030-120.9330000-9.7649.7640000000000000000000000000
Common Stock Repurchased -371.2720-382.5835.733-5.7330-5.192000-500.127000-8.286000000000000000-9.0380000000
Dividends Paid -324.912-5.531-3.849-6.951-545.857-5.128-9.425-0.011-719.985000-531.016000-377.8090-00-251.010-20.3770-125.7780-6.956-0.004-76.361000000-55.50-33.3
Other Financing Activities -61.912-218.531-52.31162.292-12.948657.834441.384167.791-716.8883.466-205.913-285.876179.9140-46.2263.572107.43500.0025.613-203.3132.25623.5250-134.20616.551.317-0.539-76.361138.857-1.546422.108000000
Financing Cash Flow -553.123-93.209-112.93-104.247-558.806324.072179.708167.78-716.8883.466-205.913-285.876656.9640-46.2263.572-270.37400.0025.613-203.3132.2563.1480-134.20616.55-5.638-0.543-76.361138.857-1.546422.108000-55.5-0-33.3
Other Information:
Effect Of Forex Changes On Cash 0.145-0.0490.030.0110.198-0.227-1.2810.5880.6220.035-0.0670.076-0.0530.043-0.034-0.02-0.0030.0220.005-0.006-0.0080.0080.0020.002000000000-000-0-0
Net Change In Cash -642.957-311.28753.09323.431-397.043535.713485.731113.587-536.378148.991,036.194-1,154.32795.42367.073701.668-365.669158.157-190.8361,133.861-889.723-115.45457.24498.037-32.536-121.66570.808827.904-795.177482.653-114.305180.63254.20422.68915.23474.591-23.18915.622-12.547
Cash At End Of Period 1,749.2962,392.2532,741.5432,688.452,665.0193,062.0622,526.3492,040.6181,927.0312,463.412,314.421,278.2262,432.5461,637.1231,570.05868.3811,234.051,075.8941,266.73132.8691,022.5931,138.0461,075.802977.7651,010.3011,131.9661,061.159233.2551,028.432545.779760.084579.454325.25302.561287.327212.736235.926220.303